ITC Has Jurisdiction Over Allegations of Induced Infringement of Method Claims

Each week, we succinctly summarize the preceding week of Federal Circuit precedential patent opinions. We provide the pertinent facts, issues, and holdings. Our Review allows you to keep abreast of the Federal Circuit’s activities – important for everyone concerned with intellectual property. We welcome any feedback you may provide. 

– Joe Robinson, Bob Schaffer, John Morrissett, Parker Hancock, Lindsay Henner and Tinh Nguyen

 

troutman-sanders-long

 

Federal Circuit Review – Issue No. 64-02
ITC Has Jurisdiction Over Allegations of Induced Infringement of Method Claims

Suprema, Inc. v. ITC, No. 2012-1170, 2015 U.S. App. LEXIS 13929 (Fed. Cir. Aug. 10, 2015) (En banc, Before Prost, C.J.; Newman, Lourie, Dyk, O’Malley, Reyna, Wallach, Taranto, Chen, and Hughes, J.) (Opinion for the court, Reyna, J.).  Click Here for a copy of the opinion.

Cross Match Technologies, Inc. (“Cross Match”) sued Mentalix Incorporated (“Mentalix”), a domestic importer of fingerprint scanners, for allegedly infringing claim 19 of its U.S. Patent 7,203,344 (“the ’344 patent”).  Cross Match also sued Suprema, Inc. (“Suprema”), the Korean developer of the imported scanners.  Claim 19 of the ’344 patent is directed to “[a] method for capturing and processing a fingerprint image.” Cross Match alleged that the two companies infringed claim 19 when Suprema’s scanners were used with Mentalix software after importation into the U.S. The International Trade Commission (“ITC”) agreed, finding that  the Mentalix software, as used on the scanners, directly infringed claim 19, and that Suprema induced the infringement by actively encouraging combining the  Mentalix software with its scanners. Further, importation of the scanners violated Section 337 of the Tariff Act of 1930 (“Section 337”). The ITC issued a limited exclusion order “covering infringing scanners, associated software, and products containing the same that were manufactured overseas by or imported by or on behalf of Suprema or Mentalix, or any entity affiliated with either company.” Mentalix and Suprema appealed the ITC’s findings of direct and indirect infringement, and requested that the ITC’s limited exclusion order be vacated.

The Federal Circuit at first reversed the ITC’s decision, reasoning that “Section 337’s language, ‘articles that infringe, is a temporal requirement and that infringement must be measured at the time of importation.” Here, the ITC lacked authority under Section 337 to issue an exclusion order “predicated on induced infringement” because the imported scanners were “not in an infringing state upon importation.” Cross Match and the ITC petitioned for a rehearing en banc.

The Federal Circuit took the case en banc, and overturned the panel decision. The Court reviewed the ITC’s interpretation of Section 337 pursuant to the Chevron framework.  Under Chevron step one, the Court found that the phrase “articles that infringe” does not “narrow the provision to exclude inducement or post-importation infringement, but instead introduces “textual uncertainty.” As Congress has not yet provided “unambiguous resolution” to the scope of “articles that infringe,” the Court proceeded to the second Chevron step.  Under Chevron step two, the Court deemed that the ITC’s interpretation of Section 337 was reasonable because it was “consistent with the statutory text, policy, and legislative history of Section 337,” as “Section 337 contemplates that infringement may occur after importation.” Further, the panel’s interpretation of Section 337 would unnecessarily “eliminate relief for the unfair trade act and induced infringement” by allowing foreign entities “to circumvent Section 337 by importing articles in a state requiring post-importation combination or modification before direct infringement could be shown.”

The Author

Joseph Robinson

Joseph Robinson has over 20 years of experience in all aspects of intellectual property law. He focuses his practice in the pharmaceutical, life sciences, biotechnology, and medical device fields. His practice encompasses litigation, including Hatch-Waxman litigation; licensing; counseling; due diligence; and patent and trademark prosecution. He has served as litigation counsel in a variety of patent and trademark disputes in many different jurisdictions, and has also served as appellate counsel before the Court of Appeals for the Federal Circuit. Joe also focuses on complex inter partes matters before the U.S Patent and Trademark Office, inventorship disputes, reexaminations and reissues. His experience includes numerous interferences, a particular advantage in new U.S. Patent and Trademark Office post-grant proceedings. He also counsels on patent–related U.S. Food and Drug Administration issues, including citizen petitions, Orange Book listing, and trademark issues. For more information and to contact Joe please visit his profile page at the Troutman Sanders website.

Joseph Robinson

Robert Schaffer is an intellectual property partner at Troutman Sanders. Bob applies more than 30 years of experience to IP counseling and litigation. His work includes patent procurement, strategic planning and transactional advice, due diligence investigations, district court patent cases, and Federal Circuit appeals. He regularly handles complex and high-profile domestic and international patent portfolios, intellectual property agreements and licensing, IP evaluations for collaborations, mergers, and acquisitions. In disputed court cases Bob’s work includes representing and counseling client in ANDA litigations, complex patent infringement cases and appeals, and multidistrict and international cases. In disputed Patent Office matters his work includes representing and counseling clients in interferences, reexaminations, reissues, post-grant proceedings, and in European Oppositions. For more information and to contact Bob please visit his profile page at the Troutman Sanders website.

Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com. Read more.

Discuss this

There are currently No Comments comments.